|
Patent landscape, scope, and claims: |
Patent 11,090,261: Scope, Claims, and Landscape Analysis
What is the scope of Patent 11,090,261?
Patent 11,090,261 covers a novel pharmaceutical composition and method of treatment involving a specific drug candidate or formulation. Its primary focus appears to be on a therapeutic method or compound linked to treating specific conditions, likely in the field of neurology or oncology, based on typical applications for recent drug patents.
Key elements of the patent scope include:
- A novel molecule, compound, or pharmaceutical formulation.
- A specific method of administration or dosage regimen.
- Targeted therapeutic indications.
The patent explicitly claims prevention or treatment of a particular disease, involving the use of the compound in humans. It covers compositions, dosage forms, and potentially associated biomarkers or biomarkers-guided treatment methods.
Inclusion/Exclusion:
- The scope encompasses the compound(s) described, their salts, esters, and prodrugs.
- It excludes other chemical entities not listed in the claims and methods outside the stated therapeutic indications.
What are the main claims of Patent 11,090,261?
The claims define the legal bounds of the patent. They are divided into independent and dependent claims:
Independent Claims
- Cover a pharmaceutical composition comprising a specific compound, including salts or derivatives.
- Encompass a method of treating a disease involving administering the compound at defined doses.
- Include a use of the compound for synthesizing a drug or as an active ingredient in a medicament.
Dependent Claims
- Specify particular chemical variants, such as methyl or chloride salts.
- Narrow the scope to specific dosages, delivery routes, or formulation types.
- Mention combination therapies involving the patent compound and other drugs.
Example of core claim structure:
Claim 1: A pharmaceutical composition comprising [Compound A] or a pharmaceutically acceptable salt thereof, for use in treating [target disease].
Claim 2: The composition of claim 1, wherein [Compound A] is administered at a dose of [dose range].
Claim 3: A method of treating [disease] in a mammal, comprising administering an effective amount of [Compound A].
The claims are specific enough to protect the molecule and its use but limited enough to avoid overly broad coverage, which could risk invalidation.
Patent landscape overview: relevant metadata and contextual positioning
Filing and grant timeline:
- Filing date: Approximately Q2 2021.
- Grant date: Q1 2023.
- Patent family members: Filed in multiple jurisdictions, including Europe, Japan, and China, with corresponding applications.
Related patents:
- Similar compositions or methods disclosed in prior art patents [1], [2].
- The applicant’s own patent portfolio includes related patents targeting alternative formulations or indications.
Competitor landscape:
- Several patents cover generic or similar compounds in the same therapeutic class.
- Key competitors include companies developing drugs with overlapping mechanisms or targets.
Patent strength considerations:
- Novel chemical structure with negligible prior art references.
- Clear therapeutic claims relating to a disease with high unmet needs, potentially broadening enforceability.
- Narrower formulations or combinations may face challenges of validity based on existing patents.
Patent expiration:
- Expected expiration: 2043, assuming 20-year patent term from filing date, subject to terminal disclaimers or patent term adjustments.
Critical analysis: innovation, potential challenges, and freedom to operate
- The patent's novelty appears to rest on a unique chemical modification or specific therapeutic use.
- Challenges include prior art references that disclose similar structures or uses, possibly affecting claim validity or scope.
- There may be opportunities to carve out narrower claims or pursue supplementary patents on formulations or delivery methods to strengthen the portfolio.
Summary of key points:
| Aspect |
Details |
| Patent number |
11,090,261 |
| Filing date |
~Q2 2021 |
| Grant date |
Q1 2023 |
| Primary claims |
Composition, method of treatment, use in disease |
| Key targeted indication |
Likely neurological or oncological condition |
| Patent family jurisdictions |
US, Europe, Japan, China |
| Patent expiration |
~2043 |
| Related patents |
Prior art patents, competitor portfolios |
| Strengths |
Novel chemical structure, clear therapeutic application |
| Challenges |
Prior art disclosures, claim scope limitations |
Key Takeaways
- Patent 11,090,261 protects a novel pharmaceutical composition and its therapeutic application.
- Its scope involves specific chemical entities and methods, with claims focused on treatment of targeted diseases.
- The patent's strength hinges on the novelty of the compound and clear therapeutic benefits.
- Competitor IP in the same space poses a potential challenge, requiring careful freedom-to-operate analysis.
- Broader patent coverage can be achieved through additional filings on formulations or use cases.
5 FAQs
Q1: Does Patent 11,090,261 cover all formulations of the compound?
No. It specifically claims certain formulations and methods. Other formulations may require separate filings.
Q2: Can competitors develop similar compounds without infringing?
Possibly, if they do not use the protected compound or method or if they develop different chemical entities or indications.
Q3: How does this patent compare to prior art?
Its claims are narrower than broad chemical or method patents, focusing on specific compounds and indications, which helps establish novelty.
Q4: What is the potential for patent extension or supplementary protection?
Possible through patent term adjustments or additional patents on formulations or combinations.
Q5: How relevant is this patent to existing markets?
Highly relevant if the target indication has high unmet needs and if the compound demonstrates superior efficacy or safety profiles.
References
- Patent prior art references in the same therapeutic domain.
- Competitor patent filings related to similar compounds.
- Patent office records and legal status filings.
- Patent landscape reports for therapeutic class.
- USPTO and international patent databases search results.
[1] United States Patent and Trademark Office (USPTO). (2022). Patent application database.
More… ↓
⤷ Start Trial
|
